Patents by Inventor Isabel Ribeiro Dos Santos

Isabel Ribeiro Dos Santos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11173131
    Abstract: The present invention relates to a transdermal device including porous microparticles capable of containing an active principle, in particular nicotine, and to the use thereof as a drug, in particular for tobacco cessation. The present invention further relates to a method for preparing a transdermal device including porous microparticles filled with an active principle.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: November 16, 2021
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Isabel Ribeiro Dos Santos, Michel Sournac
  • Publication number: 20190083416
    Abstract: The present invention relates to a transdermal device including porous microparticles capable of containing an active principle, in particular nicotine, and to the use thereof as a drug, in particular for tobacco cessation. The present invention further relates to a method for preparing a transdermal device including porous microparticles filled with an active principle.
    Type: Application
    Filed: November 16, 2018
    Publication date: March 21, 2019
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Isabel RIBEIRO DOS SANTOS, Michel SOURNAC
  • Patent number: 10154969
    Abstract: The present invention relates to a transdermal device including porous microparticles capable of containing an active principle, in particular nicotine, and to the use thereof as a drug, in particular for tobacco cessation. The present invention further relates to a method for preparing a transdermal device including porous microparticles filled with an active principle.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: December 18, 2018
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Isabel Ribeiro Dos Santos, Michel Sournac
  • Patent number: 9084730
    Abstract: The present invention relates to a solid pharmaceutical composition comprising a solid dispersion containing at least one active principle and a pharmaceutically acceptable polymer matrix, a characterized in that said pharmaceutically acceptable polymer matrix comprises a blend of (i) polydextrose, in the form of a continuous polydextrose phase, in order to promote the disintegration of the composition in an aqueous medium, and (ii) at least one polymer other than polydextrose, in the form of a continuous phase of this polymer, whereby the polydextrose is in a concentration of at least 20 wt % and the at least one polymer other than polydextrose is in a concentration of at least 20 wt % in relation to the total weight of said pharmaceutically acceptable polymer matrix.
    Type: Grant
    Filed: March 15, 2007
    Date of Patent: July 21, 2015
    Assignee: SANOFI
    Inventors: Michel Bedos, Thierry Breul, Stephen Byard, Isabel Ribeiro Dos Santos
  • Publication number: 20150045748
    Abstract: The present invention relates to a transdermal device including porous microparticles capable of containing an active principle, in particular nicotine, and to the use thereof as a drug, in particular for tobacco cessation. The present invention further relates to a method for preparing a transdermal device including porous microparticles filled with an active principle.
    Type: Application
    Filed: February 28, 2013
    Publication date: February 12, 2015
    Inventors: Isabel Ribeiro Dos Santos, Michel Sournac
  • Publication number: 20100041703
    Abstract: Rapid-disintegration monolayer film for the oral administration of active substances, comprising a water-soluble support containing at least one active substance, characterized in that it comprises a polymeric mixture of a hydrophilic film-forming agent formed from a copolymer of polyvinyl alcohol and of polyethylene glycol (PVA-PEG), of an active substance and of a hydrophilic gelling agent.
    Type: Application
    Filed: February 19, 2008
    Publication date: February 18, 2010
    Applicant: Pierre Fabre Medicament
    Inventors: Michel Sournac, Joël Bougaret, Isabel Ribeiro Dos Santos
  • Publication number: 20070243257
    Abstract: The present invention relates to a solid pharmaceutical composition comprising a solid dispersion containing at least one active principle and a pharmaceutically acceptable polymer matrix, a characterized in that said pharmaceutically acceptable polymer matrix comprises a blend of (i) polydextrose, in the form of a continuous polydextrose phase, in order to promote the disintegration of the composition in an aqueous medium, and (ii) at least one polymer other than polydextrose, in the form of a continuous phase of this polymer, whereby the polydextrose is in a concentration of at least 20 wt % and the at least one polymer other than polydextrose is in a concentration of at least 20 wt % in relation to the total weight of said pharmaceutically acceptable polymer matrix.
    Type: Application
    Filed: March 15, 2007
    Publication date: October 18, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Michel Bedos, Thierry Breul, Stephen Byard, Isabel Ribeiro Dos Santos